Hisamitsu Pharmaceutical Co., Inc.
Q3 FY02/2023 Results
This presentation material contains information that constitutes forward- looking statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ from those in the forward-looking statements as a result of various factors including changes in material circumstances.
Hisamitsu Pharmaceutical Co., Inc.
Jan. 12th, 2023
Promoting "TE-A-TE" Culture Worldwide | 1 |
Agenda
- Looking back on the Q3 FY02/2023
- Promotion of ESG
- Progress for FY02/2023
- Consolidated P&L
- Sales Results by Region
- Sales Results by Product
- Trends of 2nd-generationnon-steroidalanti-inflammatory patch in Japan
- R&D Pipeline
Promoting "TE-A-TE" Culture Worldwide | 2 |
1. Looking back on the Q3 FY02/2023(1)
Rx Business
OTC Business
Mar. ・FDA Approves Once-Daily XELSTRYM™ (dextroamphetamine) Transdermal System(Theme : ATS) , CII, for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients 6 Years and Older
Apr. ・Application for manufacturing and marketing approval of HP-5070 in Japan (primary palmar hyperhidrosis treatment drug)
Jun. ・Notification of approval for manufacturing and marketing approval of the additional indications of "low back pain, humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis" for ZICTHORU® Tapes (Transdermal, pain treatment NSAID patch, development code: HP-3150) in Japan
Oct. ・Notification of the Results of the Phase III Clinical Study of HP-5000 for Osteoarthritis Pain of the Knee in the U.S.(Pain Relief and Anti-Inflammatory Patch)
May. ・Launch of Bye Bye Fever® Band fastening type and Cooling Pillow in Japan Jun. ・Launch of new package "Nobinobi® Salonsip® Fit®H(Hot Type)"
"Nobinobi® Salonsip® Fit®α(Odorless type)", 10 patches in Japan
Jun. ・Launch of "Lifecella® SACRISE®" in Japan
Jul. ・Collaboration Campaign between "Hisamitsu Pharmaceutical" and ″Demon Slayer"
in Japan
Sep. ・Launch of new package "Feitas® Shippu", "Feitas® Shippu Onkan", 10 patches in Japan Oct. ・Obtainment of "Good Design Award 2022" for Nobinobi® Salonsip® Fit®
Oct. ・Launch of new package "Salonpas® Tsubokori® Patch", 64 patches in Japan
Promoting "TE-A-TE" Culture Worldwide | 3 |
1. Looking back on the Q3 FY02/2023(2)
Feitas®Shippu, Feitas®Shippu Onkan | Salonpas® Tsubokori® Patch |
・Use of package material reduction approximately 21%
・Amount of waste reduction | |
(2 products total) | approximately 1t/year |
Feitas®Shippu https://www.hisamitsu.info/feitas/product/24.html
Feitas®Shippu Onkan https://www.hisamitsu.info/feitas/product/25.html
・Use of package material reduction approximately 3%
・Amount of waste reduction approximately 0.09t/year
Salonpas® Tsubokori® Patch https://www.salonpas.jp/lineup/salonpas_tubokoripatch.html
Promoting "TE-A-TE" Culture Worldwide | 4 |
1. Looking back on the Q3 FY02/2023(3)
Mar. ・Notice regarding Revision of Earnings Forecast | ||
Mar. ・Acquisition of Shares of AYM HD . | ||
(AYM HD : Wholly-owningparent company of Ayumi Pharmaceutical Holdings .) | ||
Apr. ・Providing Humanitarian Assistance to Ukraine | ||
May. ・Salonpas® certified as the World's No. 1 OTC topical analgesic patch brand for | ||
the 6th consecutive year since 2016. | ||
Hisamitsu Pharmaceutical certified as the holder of the world's largest share in | ||
the corresponding market category for the 5th consecutive year since 2017. | ||
Others | *Based on research by Euromonitor International (UK) | |
Jul. ・Stock compensation-type stock options (stock acquisition rights) issue | ||
Jul. ・Finalized Stock compensation-type stock options (stock acquisition rights) issue details | ||
Sep. ・Open "Pharmaceutical Research Institute" pavilion at KidZania Fukuoka | ||
Sep. ・Passing away and resignation of an outside director | ||
Sep. ・Support for the heavy rain disaster from August 3, 2022 | ||
Sep. ・Construction of New Research Center and Reorganization of Research Sites | ||
Oct. ・Acquisition of treasury stock | ||
Oct. ・Hisamitsu Springs Practice Site Named "Salonpas® Arena" | ||
*Dec.5 | Further energy conservation and CO2 reduction efforts through the "Smart Energy Network | |
Project" at Kiyohara Industrial Park | ||
*Jan.10 Hisamitsu Pharmaceutical Hot Heart Club decided to donate to support organizations in FY2022 | ||
Promoting "TE-A-TE" Culture Worldwide | 5 | |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Hisamitsu Pharmaceutical Co. Ltd. published this content on 12 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 January 2023 06:19:11 UTC.